Your session is about to expire
← Back to Search
BI 1569912 for Major Depressive Disorder
Study Summary
This trial is for adults w/ depression who haven't had relief from other treatments. The goal is to see if a new medicine, BI 1569912, is effective & tolerable. People are randomly assigned to take BI 1569912 or a placebo, & doctors monitor their health for 5 weeks.
- Major Depressive Disorder
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment in this experiment still available for participants?
"Clinicaltrials.gov provides evidence that this clinical trial is actively enrolling participants; the trial was initiated on July 20th 2021 and lastly updated November 28th 2022."
Has BI 1569912 been cleared by the FDA for public use?
"The safety of BI 1569912 is estimated to be a 1 due to the limited information provided by Phase 1 studies, which are unable to provide sufficient evidence for efficacy and safety."
How many individuals are contributing to this research endeavor?
"This clinical trial requires 66 individuals who meet the set criteria for inclusion. Enrolment can take place at InSite Clinical Research in Hollywood, Texas and Collaborative Neuroscience Network, LLC (CNS) in DeSoto, California."
Might I be eligible to participate in this experiment?
"To be eligible for this medical trial, potential participants must experience psychosis and involutional aging. The age constraints are 18-65 years old. 66 individuals will ultimately be chosen to partake in the study."
Are there numerous health care centers conducting this experiment in North America?
"This trial is currently taking place in 6 different sites, two of which are located in Hollywood and DeSoto respectively. Additionally, Garden Grove offers another site while the other 3 centres can be found elsewhere. Participants should select the closest medical centre to reduce travelling times if they choose to join this experiment."
Does this clinical trial include elderly individuals in its recruitment?
"Patients aged 18 to 65 are eligible for this trial. For those below the age of consent, there is a current list of 191 trials; conversely, older patients can find 964 suitable studies."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger